163 related articles for article (PubMed ID: 7668062)
1. [Histologic classification and morphologic prognostic factors in malignant ovarian tumors].
Horn LC; Fricke K; Krugmann J
Zentralbl Gynakol; 1995; 117(7):335-45. PubMed ID: 7668062
[TBL] [Abstract][Full Text] [Related]
2. [Value of prognostic factors in early stage ovarian carcinoma].
Sevelda P
Zentralbl Gynakol; 1996; 118(6):326-9. PubMed ID: 8768008
[TBL] [Abstract][Full Text] [Related]
3. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
5. [Morphologic criteria of prognosis and clinical course in ovarian tumors of the borderline type].
Kühn W; Hanke J; Feichter GE; Rummel HH; Schmid H; Schmidt W; Kaufmann M
Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):173-8. PubMed ID: 3582924
[TBL] [Abstract][Full Text] [Related]
6. [Clinical course of ovarian cancer in relation to morphologic prognostic factors and cell kinetic parameters].
Kühn W; Feichter GE; Hanke J; Rummel HH; Kaufmann M; Schmid H
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):446-51. PubMed ID: 3623047
[TBL] [Abstract][Full Text] [Related]
7. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
8. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
Prat J
Mod Pathol; 2005 Feb; 18 Suppl 2():S99-111. PubMed ID: 15492758
[TBL] [Abstract][Full Text] [Related]
9. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
12. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
13. [Ovarian cancers--a solution within reach?].
Haller U; Lütolf UM; Jungi WF
Schweiz Med Wochenschr; 1983 Sep; 113(36):1300-5. PubMed ID: 6635629
[TBL] [Abstract][Full Text] [Related]
14. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
15. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
[TBL] [Abstract][Full Text] [Related]
16. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.
Sorbe B; Frankendal B; Veress B
Obstet Gynecol; 1982 May; 59(5):576-82. PubMed ID: 7070728
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in ovarian carcinoma].
Sliutz G
Wien Med Wochenschr; 1996; 146(1-2):14-7. PubMed ID: 8835490
[TBL] [Abstract][Full Text] [Related]
18. Management of borderline tumors of the ovary: state of the art.
Tropé C; Kaern J
Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
20. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
Fadare O; Mariappan MR; Wang S; Hileeto D; McAlpine J; Rimm DL
Cancer; 2004 Jun; 102(3):150-6. PubMed ID: 15211473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
